"Their effects on vaginal health are an important consideration that is often overlooked," gynecologist Melanie Bone told Newsweek.

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Kelly Osbourne once made her feelings on Ozempic very clear following her mum Sharon’s admission about the medication ...

Last week, the FDA determined the shortage of Eli Lilly tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, ...

Spinach, green tea, apples, celery, asparagus, coffee and berries are all good examples of foods high in polyphenols - which ...

Discover the complex process of thirst and the role of dopamine in satisfying our thirst. Learn how our bodies maintain water ...

Most digital health purchasers plan to increase their investments next year and are asking for risk-based contracts.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.